|
 | In Alzheimer's disease, it has become increasingly recognized that amyloid accumulation in the brain occurs decades before symptoms, such as memory loss and personality change, begin. Drugs to slow or halt progression of Alzheimer's disease will likely be most effective in those people with the least amount of brain damage, so identifying people with preclinical Alzheimer's disease will likely be crucial in developing effective treatments. | |
Preclinical Alzheimer's Disease
Preclinical refers to the early phase of a disease -- before signs and symptoms of that disease appear. An accurate diagnosis of the disease is not yet possible, but people who can be identified as having preclinical disease can be targeted for treatments that slow or halt disease progression.... Read more
| The New Perspective on Alzheimer's Disease
There is a growing consensus that the amyloid plaques that are characteristic of Alzheimer's disease actually begin accumulating in the brain decades before symptoms like memory loss and personality changes... Read more
| World Alzheimer's Day and Its Striking Report
Although it's been 25 years since the way we diagnose Alzheimer's disease was established, the rules are still in effect today.... Read more
| Current State of Diagnosing Alzheimer's
Ws luck would have it, I had the good fortune to be present at yesterday's culmination of the first Alzheimer's Breakthrough Ride at the Upper Senate Park in Washington, D.C.... Read more
| |
| | Alzheimer's Disease Ads
| | | | Featured Articles | |
| |
| | | | Sign up for more free newsletters on your favorite topics | | | | You are receiving this newsletter because you subscribed to the About Alzheimer's Disease newsletter. If you wish to change your email address or unsubscribe, please click here.
About respects your privacy: Our Privacy Policy
Contact Information:
249 West 17th Street
New York, NY, 10011
© 2010 About.com | | | | |
Must Reads | |
Advertisement
 | |
Nema komentara:
Objavi komentar